Skip to content
Aperlena

Samodzielny Publiczny Zakład Opieki Zdrowotnej Uniwersytecki Szpital Kliniczny Nr 2 Uniwersytetu Medycznego w Łodzi; Samodzielny Publiczny Zakład Opieki Zdrowotnej Uniwersytecki Szpital Kliniczny Nr 1 im. Norberta Barlickiego Uniwersytetu Medycznego w Łodzi; Samodzielny Publiczny Zakład Opieki Zdrow

Poland Łódzkie Public buyer Notices from 28 Jul 2025 to 9 Sep 2026

50 notices in the register, none open now. 27 contracts awarded, worth €188.8M in all.

Main sectors Medical equipment & pharmaceuticals 38, Software & IT systems 12

Record

Awards by year

  1. 2026 6 awards €155.4M
  2. 2025 8 awards €19.6M
  • €10.0M
  • €100.0M
  • largest, €123.8M
  • value not published

Each dot is one award, placed on its date and sized by its value.

Relations

Who wins with this buyer

  1. Fresenius Kabi Polska Sp. z o.o.; Baxter Polska Sp. z o.o.; Farmacol Logistyka Sp. z o.o.; Urtica Sp. z o.o.; Centrala Farmaceutyczna CEFARM SA; Asclepios S.A.; Neuca S.A.; Delfarma Sp. z o.o.; Aesculap Chifa Sp. z o.o.; Bialmed Sp. z o.o.; Roche Polska Sp. z o.o.; Salus International Sp. z o.o.; Im 1 contract 3.8% €123,849,683
  2. ZARYS INTERNATIONAL SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ; NEOMED POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ; "PAUL HARTMANN POLSKA" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ; COMPLIMED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ; SKAMEX SPÓŁKA AKCYJNA; LOHMANN & RAUSCHER POLSKA SPÓŁKA Z OGRANICZONĄ 1 contract 3.8% €8,766,875
  3. Baxter Polska Sp. z o.o.; Bialmed Sp. z o.o.; Farmacol Logistyka Sp. z o.o.; Salus International Sp. z o.o.; Inpharm Sp. z o.o.; Neuca S.A.; Urtica Sp. z o.o.; Genesis Pharm Sp. z o.o. Sp.K.; Medyk Lek Panek Sp. z o.o. Sp.k.; Asclepios S.A.; Komtur Polska Sp. z o. o.; Tramco Sp. z o.o.; CSL Behring 1 contract 3.8% €7,646,275
  4. Fresenius Kabi Polska Sp. z o.o.; Baxter Polska Sp. z o.o.; Bialmed Sp. z o.o.; Salus Internaional Sp. z o.o.; Meden-Inmed Sp. z o.o. 1 contract 3.8% €6,905,615
  5. Urtica Sp. z o.o.; Asclepios S.A.; Janssen-Cilag Polska Sp. z o.o.; Neuca S.A.; Farmacol Logistyka Sp. z o.o.; AstraZeneca Kft.; Komtur Polska Sp. z o. o.; Salus International Sp. z o.o.; Delfarma Sp. z o.o.; Centrala Farmaceutyczna CEFARM SA; Aesculap Chifa Spółka z ograniczoną odpowiedzialnością; 1 contract 3.8% €6,021,720
  6. Becton Dickinson Polska Sp. z o.o.; MEDIMA SP Z O.O.; VARIMED SP Z O.O.; SINMED SP Z O.O.; INTERGOS SP Z O.O.; Meden-Inmed Sp. z o.o. 1 contract 3.8% €5,186,246
  7. Medtronic Poland Spółka z o.o.; Solventum Poland Sp. z o.o.; ANMAR Sp. z o.o.; SKAMEX S.A.; MEDICAVERA; Opta-Tech Sp. z o.o. 1 contract 3.8% €4,410,219
  8. Henry Kruse Sp. z o.o.; Novax Sp. z o.o.; Medim Sp. z o.o. 1 contract 3.8% €2,813,880

Shares of the 26 awards this buyer made to a named company.

Practice

How it buys

Publishing rhythm

Publishes most in September and October.

Next likely wave: September 2027.

Typical contract value
€8,331,003
Median of the last 6 priced notices

Based on 50 notices over the last 24 months.

What to expect from this buyer

Measured in its busiest sector Medical equipment & pharmaceuticals

Typical final price against the published estimate
-19.3%

Medians across the 24 comparable awards this buyer made in this sector over the last 5 years. Each figure uses the awards that publish the dates or values it needs.

Next 90 days

Coming up from this buyer

See its forecast
tenders announced in advance (last 6 months)
0
contracts due back on the market in the next 90 days
5

Scorecard

The buyer in figures

How it runs its calls for tender

usual bidding window
15 days
of its calls state an estimated value
0%

Estimates over its calls for tender of the last 3 years, bidding windows over the last 2. Deadline extensions only where the source updates a notice in place (TED publishes corrections as separate notices, so its buyers show none).

Who wins its contracts

Many suppliers
different companies won its awards
26
of the awards went to the three most frequent winners
12%
of its calls state an estimated value
0%

Based on 26 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)
0.7
of those lots received a single tender
43%
of the awards went to companies based in another country
0%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.

Register

Tenders from this buyer

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
o
Open the result in a new tab
x
Set this result aside
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Index

Close
Log in

Language